Blue Shield of California has appointed Erin Brewer, former CFO of Lyft and strategic advisor, to its Board of Directors. Brewer brings over 25 years of leadership experience in finance, strategy, and operations across health, technology, and financial sectors. Her expertise will support Blue Shield's goals of making high-quality healthcare affordable and modernizing healthcare delivery. Brewer's appointment is expected to strengthen the board's oversight as the nonprofit health plan continues its mission to improve consumer experience and financial management sustainably.
Blue Shield of California's board appointment news is presented here with health sector market data from Pluang. For readers following health stocks, 134 of 150 priced US health-sector stocks rose while 16 fell. Notable movers include Sana Biotechnology Inc at USD 2.45 (+5.15%), Twist Bioscience Corp at USD 140.66 (-5.06%), and Eli Lilly And Co at USD 1,271.22 (+4.94%). Data is as of Oct 15, 2026 22:11 WIB.
The obesity treatment landscape is rapidly evolving with over 200 companies developing more than 200 pipeline drugs, including late-stage and early-stage clinical trials. Major pharmaceutical firms like Novo Nordisk and Eli Lilly are leading with inn...
Alice collaborated with Inflection AI and AI21 to demonstrate that NVIDIA Nemotron open models can be post-trained using real-world adversarial data to enhance AI safety and security without losing capability. Inflection AI improved conversational AI...
Stifel Nicolaus has reiterated a Buy rating for Accenture with a price target of $242, reflecting confidence in the company's strong recent stock performance and growth prospects. Accenture's shares rose 13.4% in the month leading up to October 15, 2...
Investment firm William Blair downgraded CCC Intelligent Solutions to Market Perform amid news of a $6.1 billion acquisition by a consortium led by GTCR and Elliott Investment Management. Shareholders will receive $7.75 per share, a premium over rece...
U.S. Bancorp reported third-quarter 2026 earnings per share of $1.34, exceeding analyst estimates of $1.32 and marking its fourth consecutive earnings beat. Revenue grew 8.8% year-over-year to $7.97 billion but fell just short of the $8.00 billion ex...
